Auto-injectors
fall under an important segment of medical devices designed to drug dose
delivery in a calculated manner. These injectors are used for delivering
life-saving drugs. They are extremely effective in tackling severe allergic
reactions. Auto-injectors are one of the several inventions focused toward
bettering care giving. The continuous advances in medical technology has led to
development of effective auto-injectors. Latest versions of the device are more
user-friendly and cost-efficient. These injectors are intended for
self-administration by patients. They do not require special training for
homecare givers to administer drugs. Such factors make the devices extremely
important and practical. Market Research Future (MRFR) projects that the global
auto-injectors
market companies will reach a valuation of more than USD 2 Bn by the year
2022. To reach this valuation, the market is projected to exhibit a compound annual
growth rate (CAGR) of 17.2% from 2016 to 2022.
The advent of
auto-injectors has helped in tackling the challenges faced in
self-administration. These injectors are far more superior than conventional
needle-based drug delivery devices. The technology is quite simple, as
spring-loaded system is used in for functionality. Most auto-injectors that are
currently available have plastic body, which help in deterring unnecessary
contamination. Rising incidences of allergic
diseases associated with anaphylaxis and other allergies globally is expected
to influence the global auto-injectors market.
Get Sample
Report @https://www.marketresearchfuture.com/sample_request/2046
Global Auto-Injectors
Market: Competitive Landscape
UNILIFE
CORPORATION, Enbrel, Owen Mumford Ltd., Amedra Pharmaceuticals LLC,
Scandinavian Health Ltd., and kaleo, Inc. are among the global auto-injectors
market.
Global Auto-Injectors Market: Segmental Overview
The segmental analysis of
the global auto-injectors market has been conducted on the basis of product
type, application, and suppliers.
Based on product type, the
market has been segmented into reusable, disposable and others. Based on
application, the market has been segmented into rheumatoid arthritis,
anaphylaxis, multiple sclerosis, allergies and others. Based on supplier, the
market has been segmented into retailers, pharmacy, online retailers and others.
Global Auto-Injectors Market: Regional Segmentation
Key regions mentioned in
MRFR’s report include South America, North America, Europe, Asia Pacific (APAC)
and the Middle East & Africa (MEA). In terms of revenue, North America
holds the top spot in the global auto-injectors market. In addition, the
auto-injectors market in North America is projected to reach the size of USD
0.9 Bn towards the end of assessment period. Faster uptake of advanced
technologies and presence of a robust healthcare systems in the U.S. is
supporting the market growth in the region. North America is expected to remain
a highly attractive market for auto-injectors during the forecast period.
Europe holds the second spot in the global auto-injectors market in terms of
revenue. Factors such as high healthcare expenditure and strong government
support are propelling the market in Europe. Meanwhile, the APAC auto-injectors
market is expected to exhibit a register the highest CAGR during the forecast
period.
Browse
Complete Report Details @ https://www.marketresearchfuture.com/reports/auto-injector-market-2046
The Wall